Check out our latest podcast episode on Power. Watch now!
Sales & Support: +1 800 762 3361
Member Resources
Industrial Info Resources Logo
Global Market Intelligence Constantly Updated Your Trusted Data Source for Industrial & Energy Market Intelligence
Home Page

GALWAY, IRELAND--January 22, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Buoyed by the runaway success of its diabetes and weight loss drugs Ozempic and Wegovy, Denmark's Novo Nordisk A/S (NYSE:NVO) (Bagsværd, Denmark) has plans to build a major manufacturing operation at its Grange Castle campus in Dublin, Ireland. Within this article: Details new plant investment in Dublin to boost production of Ozempic and Wegovy, scale, timeline, related European investments

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.

×
×

Contact Us

For More Info!